<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2025.1653355</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Inhibition of IL-27 signaling regulates chemokine levels and sustains CXCR2 receptor expression on mononuclear cells to improve disease outcomes during gram-negative neonatal sepsis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Annamanedi</surname>
<given-names>Madhavi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/388222/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vance</surname>
<given-names>Jordan K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3188236/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Robinson</surname>
<given-names>Cory M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1267643/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Microbiology, Immunology, &amp; Cell Biology, West Virginia University School of Medicine</institution>, <addr-line>Morgantown, WV</addr-line>,&#xa0;<country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Vaccine Development Center, West Virginia University Health Sciences Center</institution>, <addr-line>Morgantown, WV</addr-line>,&#xa0;<country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/423094/overview">Thiago DeSouza-Vieira</ext-link>, Oswaldo Cruz Foundation (Fiocruz), Brazil</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2319411/overview">Kunjan Khanna</ext-link>, Washington University in St. Louis, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/893533/overview">Filipe Pereira-Dutra</ext-link>, Oswaldo Cruz Foundation (Fiocruz), Brazil</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2671234/overview">Joana Hygino</ext-link>, Rio de Janeiro State Federal University, Brazil</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Cory M. Robinson, <email xlink:href="mailto:cory.robinson1@hsc.wvu.edu">cory.robinson1@hsc.wvu.edu</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1653355</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>08</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Annamanedi, Vance and Robinson.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Annamanedi, Vance and Robinson</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Interleukin-27 (IL-27) is a cytokine that belongs to the IL-6/IL-12 cytokine family with diverse influences on the immune response. Elevated levels of IL-27 cytokine during the neonatal period predispose neonatal mice to more severe infection. Neonatal pups deficient in IL-27 signaling exhibit improved survival and bacterial clearance with reduced systemic inflammation. However, the precise molecular mechanisms that regulate bacterial clearance and the overall immune response in IL-27 receptor a-deficient (KO) mice during neonatal sepsis remain incompletely defined.</p>
</sec>
<sec>
<title>Methods</title>
<p>Analysis of the transcriptome of the neonatal spleen during <italic>Escherichia coli</italic>-induced sepsis in IL-27R&#x3b1; KO mice identified elevated expression of the chemokine receptor gene CXCR2. Here we further explored the mechanistic insights of the CXCR2/CXCL2 signaling axis limiting the infection in WT and IL-27R&#x3b1; KO neonatal mice using an <italic>n vivo</italic> model and <italic>ex vivo</italic> studies with primary cells.</p>
</sec>
<sec>
<title>Results</title>
<p>The results uncovered that during infection WT neonatal mice fail to increase expression of CXCR2 but upregulate the cognate ligand CXCL2 significantly. Conversely, IL-27R&#x3b1; KO neonates increase CXCR2 expression significantly in the spleen during infection but fail to upregulate CXCL2 transcripts. Splenocytes isolated form septic neonatal KO mice migrated with superior efficiency towards the chemokine CXCL2 compared to WT counterparts. Surprisingly, we also found that splenic monocytes but not the neutrophils account for higher CXCR2 gene expression in the IL-27R&#x3b1; KO neonatal mice. Monocytes isolated from the spleens of both WT and IL-27R&#x3b1; KO neonatal pups confirmed that the concentration of CXCL2 regulates CXCR2 receptor expression. We further demonstrated that with regulated CXCL2 chemokine expression levels, IL-27Ra-deficient neonatal mice had more CXCR2+ mononuclear cells present at the site of infection.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>Overall, our findings suggest that during infection in the absence of IL-27 signaling, a differential expression of CXCR2 and CXCL2 promotes increased migration of mononuclear cells consistent with improved bacterial clearance and tissue homeostasis. This study defines mechanisms that improve the host response in the absence of IL-27 signaling during neonatal sepsis and reinforces the potential for antagonizing IL-27 as a host-directed therapy for neonatal sepsis.</p>
</sec>
</abstract>
<kwd-group>
<kwd>CXCR2</kwd>
<kwd>CXCL2</kwd>
<kwd>monocytes</kwd>
<kwd>chemokine</kwd>
<kwd>interleukin-27</kwd>
<kwd>neonatal sepsis</kwd>
<kwd>bacterial infection</kwd>
<kwd>bacterial clearance</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="84"/>
<page-count count="14"/>
<word-count count="6349"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Cytokines and Soluble Mediators in Immunity</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Neonatal sepsis is a dysregulated host response due to infection in the blood which occurs first 28 days of life that is life-threatening with a high rate of mortality (<xref ref-type="bibr" rid="B1">1</xref>). It is responsible for approximately 8% of all neonatal deaths and not only represents the leading cause of neonatal mortality but also contributes to long-term morbidity (<xref ref-type="bibr" rid="B2">2</xref>). Neonatal sepsis is categorized into early onset (0-3 day of life) and late onset (&gt;3 days of life). In early-onset sepsis neonates most commonly acquire infectious agents from the mother via ascension from the cervix or from the colonized birth canal at the time of delivery. Group B streptococci and <italic>E. coli</italic> are the most common aetiologic bacteria of early onset neonatal sepsis (<xref ref-type="bibr" rid="B3">3</xref>). Late onset sepsis is common in extremely low birth weight premature infants who experience longer durations in the hospital (<xref ref-type="bibr" rid="B4">4</xref>). Hospital-acquired pathogens from intensive care such as gram-positive bacteria, coagulase negative staphylococci (CoNS), and gram-negative bacterial species are commonly associated with late onset of sepsis (<xref ref-type="bibr" rid="B5">5</xref>). Treatment for neonatal sepsis is limited to a combination of antibiotics and supportive care (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). First-line treatment for neonatal sepsis is a beta-lactam antibiotic such as ampicillin combined with an aminoglycoside that is generally gentamicin. Cefotaxime or vancomycin are primary option to treat late onset sepsis (<xref ref-type="bibr" rid="B8">8</xref>). Difficulties or delayed diagnosis, selecting the wrong antibiotics, and emergence of antibiotic resistance are major treatment challenges of neonatal sepsis (<xref ref-type="bibr" rid="B9">9</xref>). Several adjuvant therapies have been explored with intravenous immunoglobulin administration among the well-studied, but these approaches have failed to change the prognosis for this serious infant disease (<xref ref-type="bibr" rid="B10">10</xref>). The neonatal immune system is not fully developed in the transition from maternal tolerance and is inefficient in the clearance of microbial pathogens (<xref ref-type="bibr" rid="B11">11</xref>). Neonates rely heavily on innate immunity that is polarized toward an anti-inflammatory state (<xref ref-type="bibr" rid="B12">12</xref>). A detailed understanding of mechanisms that can augment and improve innate immune responsiveness in neonates may facilitate the development of new therapeutic strategies to treat neonatal sepsis (<xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>Interleukin (IL)-27 is a heterodimer composed of IL-27p28 and Epstein-Barr virus&#x2013;induced 3 (EBI3) subunits that signal through a cell surface receptor composed of IL-27R&#x3b1; and gp130. IL-27 promotes Th1, Th2 and Treg cell differentiation and inhibits Th17 cell differentiation (<xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>). IL-27 is primarily produced by antigen-presenting cells such as dendritic cells, macrophages, monocytes, and more recently, B cells (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). IL-27 is known to play a role in the immune response during sepsis; serum levels are elevated during the neonatal period and increase further upon infection (<xref ref-type="bibr" rid="B19">19</xref>&#x2013;<xref ref-type="bibr" rid="B22">22</xref>). At the time of infection IL-27 promotes bacterial persistence and compromises host defense (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Loss of IL-27 signaling improves the survival rate in an experimental murine neonatal sepsis model (<xref ref-type="bibr" rid="B20">20</xref>). In a mouse model of cecal ligation and puncture (CLP)-induced acute lung injury, IL-27 neutralization lowered pulmonary inflammation and enhanced survival rate (<xref ref-type="bibr" rid="B24">24</xref>). Blockade of IL-27 signaling in a murine model of secondary <italic>Staphylococcus aureus</italic> pneumonia also improved bacterial clearance (<xref ref-type="bibr" rid="B23">23</xref>). However, understanding the precise role of IL-27 during bacterial infections early in life remains incomplete. Neonatal sepsis studies from our group using IL-27R&#x3b1;-deficient (KO) mice, revealed that absence of IL-27 signaling improved maintenance of body mass, increased bacterial clearance with reduced systemic inflammation, and decreased mortality rates in the pups (<xref ref-type="bibr" rid="B20">20</xref>). Our laboratory studied the transcriptome of the neonatal spleen during <italic>Escherichia coli</italic>-induced sepsis in wild-type (WT) and IL-27R&#x3b1;-deficient (KO) mice (<xref ref-type="bibr" rid="B25">25</xref>). Among the important findings in this work are a significant increase in expression of cytokines and chemokines during infection in WT pups that failed to upregulate in the KO pups, consistent with overall lower levels of inflammation and improved outcomes (<xref ref-type="bibr" rid="B25">25</xref>). However, in contrast to this trend, we identified elevated levels of the chemokine receptor gene, CXCR2, in the KO neonatal mice during infection that did not change significantly in WT pups (<xref ref-type="bibr" rid="B25">25</xref>).</p>
<p>CXCR2 is found on many cells including leukocytes, endothelial, and epithelial cells and is a high-affinity receptor for IL-8 in humans and CXCL2 in mice (<xref ref-type="bibr" rid="B26">26</xref>). In sepsis, the chemokine CXCL2 and its receptor CXCR2 play a critical role in neutrophil and monocyte recruitment and promotes their migration to inflammatory sites (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Here, we explored the mechanism by which elevated levels of CXCR2 aid in combating sepsis in IL-27R&#x3b1; KO neonatal mice.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Ethics statement</title>
<p>All procedures were approved by the West Virginia University Institutional Animal Care and Use Committee (Protocol #:1708008935) and conducted in accordance with the recommendations from the Guide for the Care and Use of Laboratory Animals by the National Research Council (NRC, 2011).</p>
</sec>
<sec id="s2_2">
<title>Mice</title>
<p>Breeding pairs of C57BL/6 (WT) or IL-27R&#x3b1;<sup>-/-</sup> (KO) mice on a C57BL/6 genetic background were purchased from Jackson Laboratories (Bar Harbor, ME) and maintained under specific pathogen-free conditions in the vivarium at West Virginia University Health Sciences Center. Mice were maintained on a 12-h light/dark cycle and were fed/watered ad libitum. Male and female pups (~300) were used for experimental infection. Blood and tissues were collected from mice at the appropriate age by humane procedures. Euthanasia procedures involved isoflurane inhalation at 4-5% induction.</p>
</sec>
<sec id="s2_3">
<title>Bacterial infection of neonatal mice</title>
<p>
<italic>Escherichia coli</italic> isolates with serotype O1 are invasive and frequently express the K1 capsule, a virulence factor associated to neonatal meningitis, bacteremia, and septicemia (<xref ref-type="bibr" rid="B29">29</xref>). We established a murine neonatal sepsis model using <italic>Escherichia coli</italic> strain O1:K1:H7 (ATCC 11775) obtained from the ATCC (Manassis, VA, USA). The bacteria were grown in Luria broth from a single colony isolated on Tryptic Soy agar (TSA). To prepare infectious inoculums, the bacteria were enumerated as described previously (<xref ref-type="bibr" rid="B21">21</xref>). Neonatal pups (n=3 per group [control vs. infected] per genotype [WT vs. KO]) at 4 days were inoculated subcutaneously in the scapular region with <italic>E. coli</italic> O1:K1:H7 using a 28-gauge insulin needle as described previously (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). The bacteria were washed with PBS, centrifuged at 2,000 x g for 5 min, and suspended in a volume of PBS equivalent to an inoculum of 50 &#x3bc;L/mouse. The target inoculum was 2&#xd7;10<sup>5</sup> CFUs per mouse and actual inoculums as determined by standard plate counts, ranged from 2-3x10<sup>5</sup> CFUs per mouse. Vehicle (PBS)-received pups were identified from <italic>E. coli</italic>-infected pups using a tail snip. The weights of mice were recorded immediately prior to infection, and at 24 h immediately prior to euthanasia. Blood glucose levels were measured using an AlphaTrack3 blood glucose monitoring system (Zoetis, MI, USA). All downstream experiments were associated with the same pre-identified mice. Spleens isolated from pups were placed in PBS on ice. For some experiments, spleens were placed in 4% paraformaldehyde for further histopathological studies. Blood was deposited in tubes that contained 5 &#x3bc;L of 500 mM ethylenediamine tetraacetate acid (EDTA) and placed on ice. Serum was collected by centrifuging at 2,000 x g for 10 min. The bacterial burden in the spleen was enumerated by serial dilution and standard plating on TSA.</p>
</sec>
<sec id="s2_4">
<title>RNA isolation and quantitative real time PCR</title>
<p>Spleens were homogenized in TRI Reagent<sup>&#xae;</sup> (Molecular Research Center, Cincinnati, OH). According to the commercial product protocol, the upper aqueous layer following phase separation was mixed with an equal volume of 75% ethanol and transferred to E.Z.N.A.<sup>&#xae;</sup> RNA isolation columns (Omega Biotek, GA, USA). The manufacturer&#x2019;s instructions were followed to complete tissue RNA isolation using E.Z.N.A.<sup>&#xae;</sup> RNA isolation kit (Omega Biotek, GA, USA). RNA from cells or tissue was quantified using a nanodrop. First-strand cDNA was synthesized using the iScript&#x2122; cDNA synthesis kit (Bio-Rad, CA, USA). Quantitative PCR reactions included cDNA diluted four-fold, gene-specific TaqMan<sup>&#xae;</sup> primer probe sets (ThermoFisher, MA, USA), and iQ&#x2122; Supermix (Bio-Rad, CA, USA). Cycling was performed in triplicate using a StepOnePlus&#x2122; Real-Time detection system (ThermoFisher, MA, USA). Gene-specific amplification as an internal reference gene and expressed as log<sub>2</sub> relative gene expression compared to control spleen using the formula 2<sup>-&#x394;&#x394;Ct</sup>. CXCR2 (ID: Mm. PT. 58. 12102629) and CXCL2 (ID: Mm. PT. 58.10456839) assays were purchased from Integrated DNA Technologies (Coralville, IA, USA). The &#x3b2;-actin assay (ID: mM01205647_g1) was purchased from ThermoFisher (MA, USA).</p>
</sec>
<sec id="s2_5">
<title>Chemotaxis assay</title>
<p>Splenocytes (5x10<sup>5</sup>) from infected WT and KO animals isolated as described above were added onto the membrane of the 24-transwell insert (3 &#x3bc;m pore size) in a volume of 100 &#xb5;L DMEM. A volume of 600 &#xb5;L complete DMEM with or without 0.025 ng/mL CXCL2 chemoattractant was carefully added to the well. The transwell culture was incubated at 37&#xb0;C with 5% CO<sub>2</sub>. Images of migrated cells in the medium of the bottom chamber were taken at 1 and 4 h post-incubation using an Evos imaging system (Thermo Fisher Scientific, Massachusetts, USA). Average of 4 picture fields at 10x magnification were taken for each condition and cell counts were determined using ImageJ automated software (<xref ref-type="bibr" rid="B30">30</xref>).</p>
</sec>
<sec id="s2_6">
<title>Cell separation</title>
<p>Four-day old WT (n=5) and KO (n=5) pups infected for 24 h were humanely euthanized and the spleens collected. To obtain sufficient cells for downstream analysis, spleens were pooled based on infection status (control vs. infected). Single-cell suspensions were generated by dissociating the spleens through a 40 &#xb5;m strainer and centrifugation at 350&#x2009;&#xd7;&#x2009;g for 5&#x2009;min. Cells were resuspended in 0.5 mL of ammonium/chloride/potassium erythrocytes lysis buffer (ThermoFisher Scientific, Massachusetts, USA) and incubated on ice for 5&#x2009;min, followed by centrifugation at 350&#x2009;&#xd7;&#x2009;g for 5&#x2009;min. Mononuclear leukocytes were enriched from splenocytes using Optiprep&#x2122; (Sigma-Aldrich, Illinois, USA) density gradient centrifugation as described previously and scaled down four-fold to accommodate the smaller number of cells in neonatal spleens (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Neutrophils were isolated from splenocytes with magnetically labeled anti-Ly6B.2 (7/4) microbeads and immunomagnetic selection using Miltenyi Biotec isolation reagents (Miltenyi Biotec, Bergisch Gladbach, Germany) as described previously (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B32">32</xref>) Splenocytes, monocytes and neutrophils were counted using automated cell countess 3 (Invitrogen, Massachusetts, USA) used as described in downstream approaches. The enrichment of mononuclear cells and neutrophils was assessed by immunolabeling for CD11b, Ly6C, and Ly6G, respectively.</p>
</sec>
<sec id="s2_7">
<title>Ex-vivo studies of CXCR2 expression</title>
<p>Mononuclear cells from WT and KO pups of seven day old were isolated as described above and 1&#xd7;10<sup>6</sup> cells seeded per well in a 6 well plate. These cells were treated with CXCL2 0.1&#xb5;g/mL or 1&#xb5;g/mL for 8 h. Cells were harvested, and RNA was extracted to check the gene expression of CXCR2.</p>
</sec>
<sec id="s2_8">
<title>Flow cytometry</title>
<p>5&#xd7;10<sup>5</sup> cells splenocytes or mononuclear cells were mixed with Fc receptor blocking reagent (Miltenyi Biotec, Bergisch Gladbach, Germany) and held at room temperature for 10&#x2009;min prior to cell surface marker labeling with fluorochrome-conjugated antibodies. In addition to Live/Dead stain (FVS780, BD Biosciences, CA, USA), antibodies used for the panel included CD11b (BV786) and Ly6C (PE) from BD Biosciences and CXCR2 (APC) from Miltenyi Biotec. All antibodies were diluted according to manufacturer specifications. Immunolabeling was performed for 45 min on ice protected from light. Cells were washed, resuspended in 4% paraformaldehyde (PFA; ThermoFisher Scientific, MA, USA), and stored at 4&#x2009;&#xb0;C until flow cytometric analysis. All samples were analyzed on a LSRFortessa instrument (BD Biosciences) using FCS Express version 7.0 software. A minimum of 30,000 events were analyzed per sample.</p>
</sec>
<sec id="s2_9">
<title>Pathological assessments</title>
<p>Spleens were fixed in 4% paraformaldehyde, embedded in paraffin, sectioned at a thickness of 3 &#x3bc;m, and then stained with hematoxylin &amp; eosin (H&amp;E) solution according to standard procedures performed by the Electron Microscopy Histopathology and Tissue Bank Core Facility at West Virginia University. Histopathologic changes were observed by light microscopy (Olympus slide scanner, Japan). Organ damage was evaluated by measuring aspartate aminotransferase (Cayman, MI, USA) in the serum according to manufacturer&#x2019;s protocol.</p>
</sec>
<sec id="s2_10">
<title>Statistical analysis</title>
<p>All data sets were analyzed with the appropriate parametric or nonparametric test as indicated in the figure legend using Prism 8 (GraphPad, San Diego, CA). The threshold for statistical significance was set at alpha = 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>IL-27 influences expression levels of CXCR2 in the spleen during neonatal sepsis</title>
<p>To understand the impact of IL-27 on regulation of the neonatal host response to infection, we previously analyzed the transcriptome of the neonatal spleen during K1-encapsulated <italic>E. coli</italic>-induced sepsis in WT and KO mice (<xref ref-type="bibr" rid="B25">25</xref>). KO mice do not express a functional receptor and cannot respond to IL-27. Many genes for cytokines, chemokines, and their receptors were increased in WT animals during infection, consistent with pronounced inflammation, but did not increase significantly in KO pups (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>) (<xref ref-type="bibr" rid="B25">25</xref>). In contrast, CXCR2 expression was upregulated significantly in KO neonates during infection but failed to increase in WT neonates (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A, B</bold>
</xref>) (<xref ref-type="bibr" rid="B25">25</xref>). To further confirm these findings in new sets of animals, WT and KO neonates were infected on day 4 with <italic>E. coli</italic> and the spleens collected at 24 h post-infection to determine CXCR2 gene expression. CXCR2 expression levels in the KO neonates were significantly higher during infection (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). WT neonates downregulated CXCR2 expression levels in the spleen upon <italic>E. coli</italic> infection (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>IL-27R&#x3b1; KO neonatal mice increase CXCR2 chemokine receptor expression during <italic>E. coli</italic>-induced sepsis. Neonatal WT and KO mice (n=3-4) were subcutaneously inoculated with a target of 2&#xd7;10<sup>5</sup> CFU/mouse of <italic>E. coli</italic> O1:K1:H7 or PBS as a control on day 4 of life. Spleens were collected at 24 h post-infection. <bold>(A)</bold> Heatmap visualization of expression values for a subset of genes annotated as chemokine receptors, interleukins, and chemokine ligands that are differentially expressed between WT and KO spleens in the presence or absence of <italic>E. coli</italic> infection from our previously published data (<xref ref-type="bibr" rid="B25">25</xref>). Highlighted changes in KO pups (green framed) are contrasted with those in WT pups (red framed). <bold>(B)</bold> The relative molar concentration (rmc) of a transcript in a RNA sample described previously (<xref ref-type="bibr" rid="B25">25</xref>), was measured and represented in reads per kilobase million values (RPKM). <bold>(C)</bold> Mean gene expression levels of CXCR2 &#xb1; standard error (SE) in the spleen is shown for 3 independent experiments. The expression was determined relative to uninfected control spleens by real-time PCR using the formula 2<sup>-&#x394;&#x394;Ct</sup>. Statistical significance in the 95% confidence interval was determined using individual unpaired two tailed t tests; exact P values are shown.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1653355-g001.tif">
<alt-text content-type="machine-generated">Three-part graphical representation of CXCR2 receptor expression. A: Heat map shows gene expression levels with z-scores, highlighting CXCR2 expression in wild-type (WT) and knockout (KO) samples treated with PBS or E. coli. B: Bar graph displays RPKM values with significant differences (p&lt;0.005) between conditions. C: Bar graph illustrates log2 relative changes in expression, with p-values for comparisons between groups (0.035, 0.0069, 0.05).</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_2">
<title>CXCL2 is differentially expressed in the absence of IL-27 signaling during neonatal infection</title>
<p>Transcriptome data showed that WT neonates had very high expression levels of numerous chemokines during infection (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>) (<xref ref-type="bibr" rid="B25">25</xref>). Among them CXCL2 is one of the high- affinity binding ligands for CXCR2 receptor (<xref ref-type="bibr" rid="B33">33</xref>). Gene expression data from the spleens of WT and KO neonates confirmed that during infection, CXCL2 chemokine levels were highly elevated in the WT (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2B, C</bold>
</xref>) whereas KO had moderately elevated expression (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). In contrast to the higher levels of chemokine CXCL2 levels, the receptor expression is very low in the WT infected pups (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1</bold>
</xref>, <xref ref-type="fig" rid="f2">
<bold>2</bold>
</xref>). In the spleen, although IL-27 receptor KO infected pups had moderate expression levels of chemokine CXCL2, its receptor CXCR2 levels were high (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1</bold>
</xref>, <xref ref-type="fig" rid="f2">
<bold>2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>WT neonatal mice upregulate CXCL2 chemokine expression significantly during <italic>E. coli</italic>-induced sepsis. Neonatal WT and KO mice (n=3-4) were subcutaneously inoculated with a target of 2&#xd7;10<sup>5</sup> CFU/mouse of <italic>E. coli</italic> O1:K1:H7 or PBS as a control on day 4 of life. Spleens were collected at 24 h post-infection. <bold>(A)</bold> Heatmap visualization of expression values for a subset of genes annotated as chemokine receptors, and chemokine ligands that are differentially expressed between WT (red framed) and KO (green framed) samples in the presence or absence of <italic>E. coli</italic> infection. <bold>(B)</bold> The relative molar concentration (rmc) of a transcript in a RNA sample described previously (<xref ref-type="bibr" rid="B25">25</xref>), was measured and represented in reads per kilobase million values (RPKM). <bold>(C)</bold> Mean gene expression levels of CXCL2 &#xb1; SE in the spleen are shown for 3 independent experiments. The expression was determined relative to uninfected control spleens by real-time PCR using the formula 2<sup>-&#x394;&#x394;Ct</sup>. Statistical significance in the 95% confidence interval was determined using individual unpaired two tailed t tests; exact P values are shown.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1653355-g002.tif">
<alt-text content-type="machine-generated">Analysis of CXCL2 chemokine expression. Panel A shows a heatmap of gene expression levels in wild-type (WT) and knockout (KO) with different treatments, ranging from blue (low expression) to yellow (high expression). Panel B presents a bar graph of RPKM values with significant differences (p&lt;0.001) between WT and KO under treatments. Panel C depicts a bar graph of Log2 relative change in expression with statistical significance denoted; p-values are indicated above the bars. Labels for PBS and E. coli treatments are shown below each panel.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_3">
<title>The absence of IL-27 signaling promotes effective migration of splenocytes towards chemoattractant</title>
<p>Chemotaxis of myeloid cells from the blood and bone marrow is an important process to coordinate immune responses within the spleen, enabling host response to infection and maintenance of tissue homeostasis (<xref ref-type="bibr" rid="B34">34</xref>). This chemotaxis is regulated by various factors, including chemokine receptors on cells and chemokines expressed by cells at the target tissues (<xref ref-type="bibr" rid="B35">35</xref>). To determine if increased CXCR2 expression on KO splenocytes promoted enhanced migration, we measured chemotactic migration toward CXCL2 using an <italic>in vitro</italic> Boyden chamber assay (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). WT and KO neonatal pups were infected with <italic>E. coli</italic> and spleens were harvested at 24 h post-infection (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). Splenocytes were isolated, placed in the top of the transwell, and cells migrated toward CXCL2 in the bottom well were measured by microscopy. The results demonstrated that infected KO neonatal splenocytes exhibited greater migration efficiency compared to infected WT neonatal cells over 1-4 h (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3B, C</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Efficient migration of neonatal splenocytes from infected IL-27R&#x3b1; KO pups towards chemoattractant. Splenocytes were prepared at 24 h post-infection from the spleens of neonatal mice infected with 2&#xd7;10<sup>5</sup> CFUs of <italic>E coli</italic> O1:K1:H7 (n=4-5) on day 4 of life. The cells were placed in a 3 &#x3bc;m pore size trans-well insert with complete media &#xb1; CXCL2 placed in the bottom chamber. Migrated cells were imaged and counted at 1 and 4 h post-incubation. <bold>(A)</bold>. Schematic representation of the methodology. <bold>(B)</bold>. Representative images of migrated cells at the indicated time point and condition; scale bar is 400&#xb5;m. <bold>(C)</bold>. Quantification of WT and KO cells migrating towards the chemo-attractant in relative to control (without CXCL2) for 1 and 4 h Data shown was obtained from at least 4 picture fields at 10x total magnification per experiment from a combined 3 independent experiments. Statistical significance was determined using individual unpaired two tailed t tests; exact P values are shown.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1653355-g003.tif">
<alt-text content-type="machine-generated">Panel A shows a diagram of mice infected with E. coli, detailing the procedure for extracting splenocytes and detecting cell migration. Panel B shows microscopic images of cell migration in infected wild-type (WT) and knockout (KO) mice with and without CXCL2 after one and four hours. Panel C presents a bar graph comparing the number of migrated cells in infected WT and KO with CXCL2, highlighting significant differences at one hour and four hours. Numbers and scale bars are included for reference.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_4">
<title>CXCR2 gene expression is selectively increased in the mononuclear cell population of the spleen in the absence of IL-27 signaling during infection</title>
<p>CXCR2 is expressed by mixed phagocytic myeloid cells such as neutrophils, monocytes, and macrophages and mediates migration of inflammatory cells (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>). The role of CXCR2 in neutrophil recruitment to inflammatory sites has been well established and shown to control the magnitude of the macrophage-dependent inflammatory response (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). It is also known to regulate monocyte recruitment and function (<xref ref-type="bibr" rid="B40">40</xref>). After confirming elevated levels of CXCR2 and migration efficiency of KO splenocytes infected neonatal mice, we investigated the specific cell type influencing CXCR2 expression levels in the spleen. As such, we isolated neutrophils and mononuclear cells from the spleens of control and infected WT and KO neonatal mice. Anti-Ly6B2 magnetic beads were used to enrich neutrophils, and monocytes were isolated by density gradient centrifugation (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>). We observed an approximate two-fold increase in CXCR2 expression in splenic neutrophils from WT pups during infection relative to uninfected controls (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). In contrast, there was no change in CXCR2 expression during infection in neutrophils from KO pups (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Surprisingly, there was no significant change in the CXCR2 expression observed in splenic mononuclear cells from WT pups during infection (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). However, a dramatic 32-fold increase of CXCR2 expression levels observed in the mononuclear cells of infected KO neonates relative to uninfected controls (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>CXCR2 expression is selectively increased in splenic mononuclear cells during neonatal infection in the absence of IL-27 signaling. Neonatal WT and KO mice were subcutaneously inoculated with a target inoculum of 2&#xd7;10<sup>5</sup> CFU/mouse of <italic>E. coli</italic> O1:K1:H7 (n=5) or PBS (n=5) as a control on day 4 of life. Spleens were collected at 24 h post-infection for enrichment of neutrophils and mononuclear cells. Mean gene expression levels of CXCR2 &#xb1; SE in <bold>(A)</bold> neutrophils or <bold>(B)</bold> mononuclear cells from a combined 3 independent experiments. The expression was determined relative to uninfected control spleens by real-time PCR using the formula 2<sup>-&#x394;&#x394;Ct</sup>. Statistical significance was determined using individual unpaired two tailed t tests; exact P values are shown.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1653355-g004.tif">
<alt-text content-type="machine-generated">Bar graphs depict the CXCR2 log2 relative change in gene expression in neutrophils and mononuclear cells. Neutrophils from WT infected (E.coli) shows increased CXCR2 exprssion compared to PBS control, with a significance of 0.0046. Knockout (KO) cells show no significant change (ns) between treatments. Mononuclear cells from KO pups exhibit a significant CXCR2 expression increase with E. coli exposure marked at 0.0005 compared to uninfected KO pups. WT mononuclear cells shows no difference in CXCR2 expression during infection. Error bars indicate variability.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_5">
<title>Chemokine CXCL2 levels regulate CXCR2 receptor expression on neonatal mononuclear cells</title>
<p>It is known that overproduction of proinflammatory mediators or persistent exposure to ligand during severe sepsis leads to desensitization of CXCR2 receptor (<xref ref-type="bibr" rid="B43">43</xref>). We hypothesized that highly elevated expression levels of CXCL2 chemokine in the WT might be suppressing the expression of chemokine receptor on mononuclear cells during infection. To evaluate this, mononuclear cells were isolated from na&#xef;ve WT and KO neonatal mice and stimulated with a range of CXCL2 concentrations ex vivo. The results demonstrated that mononuclear cells from both WT and KO pups exhibited elevated expression levels of CXCR2 when stimulated with 0.1 &#x3bc;g/mL of chemokine CXCL2 (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, B</bold>
</xref>). In contrast, at higher concentration of CXCL2 downregulated the expression of CXCR2 on murine neonatal mononuclear cells (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, B</bold>
</xref>). This suggests that mononuclear cells from IL-27Ra KO mice are not inherently programmed to express CXCR2 at higher levels than WT, and instead, respond to the environment during infection to modulate their receptor expression level (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>CXCL2 levels regulate CXCR2 receptor expression on neonatal mononuclear cells. Spleens from neonatal WT and KO mice (n=5) were collected on day 7 of life and monocytes were isolated. Cells were stimulated with 0.1 or 1 &#xb5;g/mL CXCL2 for 8 h Mean gene expression levels of CXCR2 &#xb1; SE in <bold>(A)</bold> WT or <bold>(B)</bold> KO mononuclear cells are shown for a combined 3 independent experiments. The expression was determined relative to control by real-time PCR using the formula 2<sup>-&#x394;&#x394;Ct</sup>. Statistical significance was determined using ANOVA; exact P values are shown. <bold>(C)</bold> A schematic to illustrate that lower levels of CXCL2 (green) regulate an increase in CXCR2 expression that is turned off by higher levels of ligand (red).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1653355-g005.tif">
<alt-text content-type="machine-generated">Graphs and illustration showing the effect of CXCL2 on CXCR2 expression levels. Graph A shows WT cells and graph B shows KO cells, each indicating higher expression of CXCR2 at a lower dose (0.1 &#x3bc;g/mL) and decreased  in CXCR2 expression levels at a higher dose of 1 &#x3bc;g/mL of CXCL2, compared to control. Graphs include significance values (A: 0.001, B: 0.0493). The illustration (C) depicts monocyte interaction with varying CXCL2 levels, showing moderate levels leading toCXCR2 expression and high levels causing CXCR2 reduction.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_6">
<title>
<italic>E. coli</italic>-infected IL-27R&#x3b1; KO neonates have an expanded population of CXCR2<sup>+</sup> Ly6C<sup>hi</sup> monocytes in the spleen</title>
<p>Recruitment of monocytes is essential for effective control and clearance of bacterial infections. Monocytes originate from progenitors in the bone marrow and traffic via the bloodstream to peripheral tissues (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>). Monocytes are classified mainly into two subsets with different biological functions based on chemokine receptor expression and the presence of specific surface molecules (<xref ref-type="bibr" rid="B46">46</xref>). In mice, classical Ly6C<sup>hi</sup> monocytes are often referred to as inflammatory monocytes which are rapidly recruited to sites of infection and differentiate further into pro-and anti-inflammatory macrophages which can clear bacteria and promote tissue remodeling or injury (<xref ref-type="bibr" rid="B47">47</xref>). To further understand the abundance and phenotype of the monocyte population in the spleen, we isolated mononuclear cells from both WT and KO neonatal mice in the presence and absence of infection at 24 h post-infection for analysis by flow cytometry (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). We consistently observed a higher percentage of Ly6C<sup>+</sup> mononuclear cells that expressed CXCR2 in the infected KO neonates than the WT neonatal pups. (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>). These findings mirror the CXCR2 gene expression profiles and suggest enhanced monocyte recruitment to sites of infection.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>
<italic>E. coli</italic>-infected IL-27Ra KO neonates have an expanded population of CXCR2<sup>+</sup> Ly6C<sup>hi</sup> mononuclear cells in the spleen. Neonatal WT and KO mice were subcutaneously inoculated with a target of 2&#xd7;10<sup>5</sup> CFUs of <italic>E coli</italic> O1:K1:H7 (n=5) or PBS (n=5) as a control on day 4 of life. Spleens were harvested at 24 h post-infection and mononuclear cells isolated by density gradient centrifugation. <bold>(A)</bold> Cells were then stained with antibodies for CD11b, Ly6C, or CXCR2 and analyzed using flow cytometry. The expression of Ly6C and CXCR2 in the single cell live CD11b<sup>+</sup> cell gate is shown. <bold>(B)</bold> The mean percentage &#xb1; SE of Ly6C<sup>+</sup> CXCR2<sup>+</sup> cells from a combined 3 independent experiments is shown. Statistical significance was determined using ANOVA; exact P values are shown.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1653355-g006.tif">
<alt-text content-type="machine-generated">Flow cytometry dot plots (A) and a bar chart (B) display the percent of CXCR2-positive and Ly6C-positive cells following different treatments. The plots show wild-type (WT) and knockout (KO) cells treated with PBS or E. coli. The percentages in boxes indicate the cells expressing the markers: WT PBS (1.31%), WT E. coli (0.96%), KO PBS (4.28%), and KO E. coli (18.75%). The bar chart compares these groups, highlighting statistically significant differences with p-values indicated by lines above the bars. KO cells with E. coli have the highest percentage of marker expression.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_7">
<title>Loss of IL-27 signaling reduces tissue injury in the spleen that is consistent with improved morbidity during infection</title>
<p>The spleen is the largest lymphoid tissue and plays an important role in the immune defense to invasive infection, particularly for encapsulated bacteria, and is a key contributor to the exaggerated inflammatory response that occurs during sepsis (<xref ref-type="bibr" rid="B48">48</xref>). To explore the potential impact of increased mononuclear cell recruitment in the context of bacterial clearance and tissue injury, we examined spleens harvested at 24 h post-infection from each genotype and treatment condition for bacterial burdens and histopathology. We observed that spleens from infected IL-27R&#x3b1; KO neonates have well-maintained tissue architecture with minimal damage, in contrast to spleens from the infected WT neonates that demonstrated necrotic regions with shrunken and fragmented cells consistent with increased bacterial burdens (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7A, B</bold>
</xref>). Serum ALT and AST levels are a reliable diagnostic tool for sepsis and septic shock that aid in predicting mortality (<xref ref-type="bibr" rid="B49">49</xref>). Serum aspartate transaminase (AST) is an enzyme found in the liver, muscles, and other tissues; levels are typically low in the blood and increase following release from damaged cells (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>). Elevated levels of AST in the serum correlate with tissue damage or apoptosis, inflammatory liver disease, septic shock, skeletal muscle injury and severe myocardial ischemia (<xref ref-type="bibr" rid="B52">52</xref>). A hallmark of sepsis is dysfunction and damage to multiple organs (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>), and as such, we measured serum AST levels as an indicator of tissue damage. We found a significant increase in serum AST levels during infection of WT neonates. However, AST levels in KO neonates remained comparable to uninfected control pups (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>). This suggests more limited tissue damage in the KO neonates during infection, in agreement with histological analysis of the spleen. As additional measures of morbidity, we also observed significant weight loss (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>) and hypoglycemia (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7E</bold>
</xref>), in the infected WT neonates. Conversely, infected KO neonates demonstrated improved maintenance of weight and blood glucose (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7D, E</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Tissue injury and sepsis-related morbidity is improved in IL-27R&#x3b1; KO neonates during infection. Neonatal WT and KO mice were subcutaneously inoculated with a target of 2&#xd7;10<sup>5</sup> CFUs of <italic>E coli</italic> O1:K1:H7 (n=2-3) or PBS (n=2-3) in each experiment as a control on day 4 of life. Weights were measured at 24 h post-infection immediately prior to collection of blood for glucose or serum analysis and spleens for histopathology. <bold>(A)</bold> Representative H&amp;E-stained sections of spleen from PBS or <italic>E. coli</italic>-inoculated neonatal mice. Red arrows indicate necrotic cells and tissue degeneration. <bold>(B)</bold> Mean bacterial burdens &#xb1; SE in the spleen, <bold>(C)</bold> Mean serum AST levels &#xb1; SE, and <bold>(D)</bold> mean weights and <bold>(E)</bold> blood glucose values are shown. Each symbol represents an individual mouse from 3 combined experiments. Statistical significance was determined using ANOVA; exact P values are shown.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1653355-g007.tif">
<alt-text content-type="machine-generated">Panel A shows histological images comparing spleen tissues: PBS-treated WT, E. coli-infected WT, PBS-treated KO, and E. coli-infected KO. Panels B to E display bar graphs comparing WT and KO mice. Panel B shows CFU per spleen; Panel C presents AST levels; Panel D indicates weight gain; Panel E shows blood glucose levels. Statistical significance is marked, highlighting differences between groups.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>neonatal period marks a time of vulnerability and susceptibility to infection with an untrained and suppressive immune environment under adaptation (<xref ref-type="bibr" rid="B55">55</xref>). Treatment of neonatal sepsis is a complex clinical challenge as combating both the infection and pathological inflammation is obligatory to improve outcomes (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>). Cytokines are important regulators of the immune response, which have a key role in the pathophysiology underlying sepsis (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>). Neonates exhibit elevated levels of IL-27, and its signaling compromises control of bacteria (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). In a murine model of neonatal sepsis, mice deficient in IL-27 signaling exhibited reduced mortality, increased weight gain, and better control of bacteria with reduced systemic inflammation (<xref ref-type="bibr" rid="B20">20</xref>). The latter is important as strategies to prime or enhance an inflammatory response in neonates to combat the bacterial burden would likely be met with enhanced pathology. Increased clearance of bacteria without inflammation toll suggests a superior formula for bacterial clearance in the absence of IL-27 signaling. This likely involves the regulatory influence of IL-27 on lysosomal activity but may also involve additional undescribed mechanisms (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B61">61</xref>). Enhanced understanding of the mechanisms by which the absence of IL-27 signaling in neonates promotes resistance to sepsis may lead to development of novel therapeutic approaches. The transcriptome analysis of spleens from <italic>Escherichia coli</italic>-induced septic IL-27R&#x3b1;-deficient (KO) neonatal mice demonstrated elevated levels of CXCR2 gene expression (<xref ref-type="bibr" rid="B25">25</xref>). Here, we further investigated this finding and the impact on immune cell recruitment and the host response during neonatal infection.</p>
<p>CXCR2 plays a central role in the recruitment of circulating neutrophils to sites of inflammation (<xref ref-type="bibr" rid="B62">62</xref>). Cummings and colleagues investigated the effect of severe sepsis on the expression and function of the two CXC chemokine receptors on circulating polymorphonuclear neutrophils and found that CXCR2 expression was reduced by 50% in septic patients (<xref ref-type="bibr" rid="B63">63</xref>). A separate group reported that down-regulation of CXCR2 on neutrophils prevents migration to the site of infection during severe sepsis (<xref ref-type="bibr" rid="B64">64</xref>). We also observed the similar finding of decreased CXCR2 expression levels in the spleen of WT pups during sepsis. Surprisingly, IL-27 receptor KO pups displayed increased levels of CXCR2 in the spleen during sepsis. In contrast to the decreased levels of receptor, its ligand CXCL2 expression was highly upregulated in the WT pups during infection. We demonstrated that purified CXCL2 protein regulated CXCR2 expression in a concentration dependent manner on splenic mononuclear cells. Elevated expression of CXCL2 in the spleens of WT neonates was consistent with reduced expression of CXCR2 on the infected WT splenocytes and consequently their migration towards chemokine <italic>in vitro</italic> was diminished. Conversely, CXCL2 expression was more tightly controlled in the absence of IL-27 signaling, consistent with a higher level of CXCR2 expression. Splenocytes from infected KO pups migrated efficiently towards chemoattractant due to higher CXCR2 receptor expression.</p>
<p>Though the CXCR2 is predominantly expressed on neutrophils, several studies found that upregulation of CXCR2 caused chemotaxis of monocytes and increased monocyte adhesion to endothelial cells (<xref ref-type="bibr" rid="B65">65</xref>&#x2013;<xref ref-type="bibr" rid="B67">67</xref>). In our neonatal <italic>E. coli</italic>-induced sepsis mouse model, we found significantly upregulated CXCR2 expression levels in splenic mononuclear cells but not neutrophils of IL-27 receptor KO pups. Neonatal neutrophils differ in their functionality compared to neutrophils of adults. Neutrophils from neonates exhibit a reduced ability to adhere to endothelial surfaces and more limited migration towards chemoattractant resulting in decreased efficiency at combating infections (<xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B69">69</xref>). Furthermore, newborns possess a significant population of neutrophils with immune suppressive characteristics known as granulocytic/polymorphonuclear myeloid-derived suppressor cells that inhibit the function of T-cells (GR-MDSC) (<xref ref-type="bibr" rid="B70">70</xref>&#x2013;<xref ref-type="bibr" rid="B73">73</xref>). In septic patients, neutrophils can also play a harmful role by facilitating tissue damage and immune-related organ failure; depletion of neutrophils has been shown to significantly reduce lung and liver injury (<xref ref-type="bibr" rid="B74">74</xref>). Although neutrophils play a key role in releasing cytokines, as well as phagocytosis and killing of bacteria, dysregulated activity during sepsis further contributes to secondary complications. Conversely, monocytes are central regulators of the inflammatory response and are potential critical elements for the genesis and resolution of sepsis (<xref ref-type="bibr" rid="B75">75</xref>). Monocytes from septic patients are modulated/reprogrammed rather than hyporesponsive during sepsis and this modulation may represent the return to homeostasis in cases of successful antimicrobial therapy and recovery of underlying disease (<xref ref-type="bibr" rid="B76">76</xref>&#x2013;<xref ref-type="bibr" rid="B78">78</xref>). Monocytes, through rapid differentiation, can expand to macrophages that play essential roles throughout all phases of sepsis and affect both immune homeostasis and inflammatory processes (<xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B80">80</xref>). CXCR2<sup>+</sup> mononuclear cells from the infected KO pups exhibited a CD11b<sup>+</sup>Ly6C<sup>+</sup> phenotype. Monocytes with this cell surface marker profile have potential to rapidly differentiate into macrophages when they reach tissues. Importantly, we cannot definitively state that all the CD11b<sup>+</sup>Ly6C<sup>+</sup>CXCR2<sup>+</sup> cells were derived from recruited monocytes. It is likely that many were recruited but some of this population may represent tissue resident cells. Nonetheless, present findings suggest that more efficient recruitment of monocytes may contribute to the explanation of our previous observation of improved bacterial phagocytosis and clearance in the peripheral tissues of infected IL-27Ra KO compared to WT mouse pups (<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>The initial stage of sepsis triggers excessive release of pro-inflammatory cytokines and chemokines, including CXCL2 (<xref ref-type="bibr" rid="B81">81</xref>). Several studies have shown that, prolonged or intense exposure to high levels of CXCL2 desensitize and internalize CXCR2 receptors on the surface of neutrophils. This weakens their ability to migrate to the site of infection and eventually impairs pathogen clearance (<xref ref-type="bibr" rid="B82">82</xref>&#x2013;<xref ref-type="bibr" rid="B84">84</xref>). In contrast to prior work, in this study we identified CXCR2 receptor desensitization on the mononuclear cells at high concentration of CXCL2. Mononuclear cells from both WT and KO pups exhibited higher expression levels of CXCR2 at lower concentration of CXCL2, whereas higher concentration of CXCL2 downregulated the CXCR2 receptor expression.</p>
<p>Our future studies aim to determine whether the neutralization of IL-27 cytokine using antibody promotes CXCR2 expression. Limitations of this study include a detailed analysis of the source of CXCL2 in the spleen during infection. Additional single cell studies will be required to understand this thoroughly. Furthermore, a time course kinetic analysis of CXCR2 expression on mononuclear cells and neutrophils in the peripheral blood and bone-marrow was not performed. Consequently, we cannot exclude the onset of changes in CXCR2 expression profiles prior to arrival at the spleen. In conclusion, regulated levels of proinflammatory cytokine (<xref ref-type="bibr" rid="B20">20</xref>) and chemokine during <italic>E. coli</italic> infection in IL-27 receptor KO neonatal mice, retains CXCR2 expression on the splenic monocyte which causes effective migration to the site of infection and is consistent with effective bacterial clearance and tissue homeostasis. Limiting IL-27 signaling in neonates has the potential to balance the immune response during infection with maximum bacterial clearance, minimal tissue damage and improved survival (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Regulation of immune mechanisms during neonatal sepsis in IL-27R&#x3b1; KO mice. Inhibition of IL-27 signaling in neonatal mice leads to elevated expression levels of CXCR2 in splenic monocytes due to regulated chemokine levels. Upregulation of CXCR2 subsequently enhances the chemotaxis toward CXCL2. The CXCR2<sup>+</sup> Ly6C<sup>hi</sup> mononuclear cells in the spleen promote bacterial clearance and tissue repair in KO neonatal mice during sepsis that ultimately leads to improved survival.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1653355-g008.tif">
<alt-text content-type="machine-generated">Comparison diagram of WT and KO mice after E. coli infection. On the left, WT mice have high CXCL2 levels leading to decreased monocyte migration, impaired bacterial clearance, organ failure, and septic pups. On the right, KO mice with chemokine CXCL2 regulation show increased monocyte migration, efficient bacterial clearance, tissue homeostasis, lesser organ damage, and sepsis survival.</alt-text>
</graphic>
</fig>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</uri>, GSE220050.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by West Virginia University Institutional Animal Care and Use Committee (IACUC) and conducted in accordance with the recommendations from the Guide for the Care and Use of Laboratory Animals by the National Research Council (NRC, 2011). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>MA: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Investigation, Project administration, Formal analysis, Data curation, Validation, Methodology, Conceptualization, Visualization. JV: Writing &#x2013; review &amp; editing, Formal analysis, Data curation. CR: Software, Formal analysis, Funding acquisition, Resources, Visualization, Supervision, Project administration, Conceptualization, Methodology, Writing &#x2013; review &amp; editing, Investigation.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. This study was supported by NIH grants AI154129 and AI163333. Additional support is provided for WVU Flow Cytometry and Single Cell Core Facility (TME CoBRE GM121322, WVCTS GM104942, WV-INBRE GM103434, S10 OD016165).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2025.1653355/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2025.1653355/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vincent</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>Sepsis and infection: Two words that should not be confused</article-title>. <source>Front Med (Lausanne)</source>. (<year>2023</year>) <volume>10</volume>:<elocation-id>1156732</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmed.2023.1156732</pub-id>, PMID: <pub-id pub-id-type="pmid">36968843</pub-id></citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milton</surname> <given-names>R</given-names>
</name>
<name>
<surname>Gillespie</surname> <given-names>D</given-names>
</name>
<name>
<surname>Dyer</surname> <given-names>C</given-names>
</name>
<name>
<surname>Taiyari</surname> <given-names>K</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Thomson</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study</article-title>. <source>Lancet Glob Health</source>. (<year>2022</year>) <volume>10</volume>:<page-range>e661&#x2013;e72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2214-109X(22)00043-2</pub-id>, PMID: <pub-id pub-id-type="pmid">35427523</pub-id></citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stoll</surname> <given-names>BJ</given-names>
</name>
<name>
<surname>Puopolo</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Hansen</surname> <given-names>NI</given-names>
</name>
<name>
<surname>Sanchez</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Bell</surname> <given-names>EF</given-names>
</name>
<name>
<surname>Carlo</surname> <given-names>WA</given-names>
</name>
<etal/>
</person-group>. <article-title>Early-onset neonatal sepsis 2015 to 2017, the rise of escherichia coli, and the need for novel prevention strategies</article-title>. <source>JAMA Pediatr</source>. (<year>2020</year>) <volume>174</volume>:<elocation-id>e200593</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jamapediatrics.2020.0593</pub-id>, PMID: <pub-id pub-id-type="pmid">32364598</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadav</surname> <given-names>P</given-names>
</name>
<name>
<surname>Yadav</surname> <given-names>SK</given-names>
</name>
</person-group>. <article-title>Progress in diagnosis and treatment of neonatal sepsis: A review article</article-title>. <source>JNMA J Nepal Med Assoc</source>. (<year>2022</year>) <volume>60</volume>:<page-range>318&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.31729/jnma.7324</pub-id>, PMID: <pub-id pub-id-type="pmid">35633256</pub-id></citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flannery</surname> <given-names>DD</given-names>
</name>
<name>
<surname>Edwards</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Coggins</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Horbar</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Puopolo</surname> <given-names>KM</given-names>
</name>
</person-group>. <article-title>Late-onset sepsis among very preterm infants</article-title>. <source>Pediatrics</source>. (<year>2022</year>) <volume>150</volume>:<elocation-id>e2022058813</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1542/peds.2022-058813</pub-id>, PMID: <pub-id pub-id-type="pmid">36366916</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="book">
<source>Guideline: managing possible serious bacterial infection in young infants when referral is not feasible</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO Guidelines Approved by the Guidelines Review Committee</publisher-name> (<year>2015</year>).</citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="book">
<source>Neonatal infection: antibiotics for prevention and treatment</source>. <publisher-loc>London</publisher-loc>: <publisher-name>National Institute for Health and Care Excellence: Guidelines</publisher-name> (<year>2024</year>).</citation></ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korang</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Safi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gluud</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lausten-Thomsen</surname> <given-names>U</given-names>
</name>
<name>
<surname>Jakobsen</surname> <given-names>JC</given-names>
</name>
</person-group>. <article-title>Antibiotic regimens for neonatal sepsis - a protocol for a systematic review with meta-analysis</article-title>. <source>Syst Rev</source>. (<year>2019</year>) <volume>8</volume>:<fpage>306</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13643-019-1207-1</pub-id>, PMID: <pub-id pub-id-type="pmid">31805993</pub-id></citation></ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sokou</surname> <given-names>R</given-names>
</name>
<name>
<surname>Parastatidou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Konstantinidi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tsantes</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Iacovidou</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Editorial: Neonatal sepsis: current insights and challenges</article-title>. <source>Front Pediatr</source>. (<year>2024</year>) <volume>12</volume>:<elocation-id>1427503</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fped.2024.1427503</pub-id>, PMID: <pub-id pub-id-type="pmid">38868391</pub-id></citation></ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carbone</surname> <given-names>F</given-names>
</name>
<name>
<surname>Montecucco</surname> <given-names>F</given-names>
</name>
<name>
<surname>Sahebkar</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Current and emerging treatments for neonatal sepsis</article-title>. <source>Expert Opin Pharmacother</source>. (<year>2020</year>) <volume>21</volume>:<page-range>549&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14656566.2020.1721464</pub-id>, PMID: <pub-id pub-id-type="pmid">32011188</pub-id></citation></ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsafaras</surname> <given-names>GP</given-names>
</name>
<name>
<surname>Ntontsi</surname> <given-names>P</given-names>
</name>
<name>
<surname>Xanthou</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Advantages and limitations of the neonatal immune system</article-title>. <source>Front Pediatr</source>. (<year>2020</year>) <volume>8</volume>:<elocation-id>5</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fped.2020.00005</pub-id>, PMID: <pub-id pub-id-type="pmid">32047730</pub-id></citation></ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kollmann</surname> <given-names>TR</given-names>
</name>
<name>
<surname>Kampmann</surname> <given-names>B</given-names>
</name>
<name>
<surname>Mazmanian</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Marchant</surname> <given-names>A</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny</article-title>. <source>Immunity</source>. (<year>2017</year>) <volume>46</volume>:<page-range>350&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2017.03.009</pub-id>, PMID: <pub-id pub-id-type="pmid">28329702</pub-id></citation></ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pflanz</surname> <given-names>S</given-names>
</name>
<name>
<surname>Timans</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>J</given-names>
</name>
<name>
<surname>Rosales</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kanzler</surname> <given-names>H</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells</article-title>. <source>Immunity</source>. (<year>2002</year>) <volume>16</volume>:<page-range>779&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1074-7613(02)00324-2</pub-id>, PMID: <pub-id pub-id-type="pmid">12121660</pub-id></citation></ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collison</surname> <given-names>LW</given-names>
</name>
<name>
<surname>Workman</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Kuo</surname> <given-names>TT</given-names>
</name>
<name>
<surname>Boyd</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Vignali</surname> <given-names>KM</given-names>
</name>
<etal/>
</person-group>. <article-title>The inhibitory cytokine IL-35 contributes to regulatory T-cell function</article-title>. <source>Nature</source>. (<year>2007</year>) <volume>450</volume>:<page-range>566&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature06306</pub-id>, PMID: <pub-id pub-id-type="pmid">18033300</pub-id></citation></ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziblat</surname> <given-names>A</given-names>
</name>
<name>
<surname>Domaica</surname> <given-names>CI</given-names>
</name>
<name>
<surname>Spallanzani</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Iraolagoitia</surname> <given-names>XL</given-names>
</name>
<name>
<surname>Rossi</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Avila</surname> <given-names>DE</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness</article-title>. <source>Eur J Immunol</source>. (<year>2015</year>) <volume>45</volume>:<fpage>192</fpage>&#x2013;<lpage>202</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201444699</pub-id>, PMID: <pub-id pub-id-type="pmid">25308526</pub-id></citation></ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>WD</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>AF</given-names>
</name>
</person-group>. <article-title>An updated advancement of bifunctional IL-27 in inflammatory autoimmune diseases</article-title>. <source>Front Immunol</source>. (<year>2024</year>) <volume>15</volume>:<elocation-id>1366377</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2024.1366377</pub-id>, PMID: <pub-id pub-id-type="pmid">38566992</pub-id></citation></ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hunter</surname> <given-names>CA</given-names>
</name>
</person-group>. <article-title>The immunobiology of interleukin-27</article-title>. <source>Annu Rev Immunol</source>. (<year>2015</year>) <volume>33</volume>:<page-range>417&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-032414-112134</pub-id>, PMID: <pub-id pub-id-type="pmid">25861977</pub-id></citation></ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klarquist</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cross</surname> <given-names>EW</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Willett</surname> <given-names>B</given-names>
</name>
<name>
<surname>Aldridge</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Caffrey-Carr</surname> <given-names>AK</given-names>
</name>
<etal/>
</person-group>. <article-title>B cells promote CD8 T cell primary and memory responses to subunit vaccines</article-title>. <source>Cell Rep</source>. (<year>2021</year>) <volume>36</volume>:<fpage>109591</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2021.109591</pub-id>, PMID: <pub-id pub-id-type="pmid">34433030</pub-id></citation></ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>KD</given-names>
</name>
<name>
<surname>Kangelaris</surname> <given-names>KN</given-names>
</name>
<name>
<surname>Lahni</surname> <given-names>P</given-names>
</name>
<name>
<surname>Calfee</surname> <given-names>CS</given-names>
</name>
</person-group>. <article-title>Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults</article-title>. <source>J Crit Care</source>. (<year>2014</year>) <volume>29</volume>:<page-range>718&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jcrc.2014.04.004</pub-id>, PMID: <pub-id pub-id-type="pmid">24848949</pub-id></citation></ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seman</surname> <given-names>BG</given-names>
</name>
<name>
<surname>Vance</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Rawson</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Witt</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Huckaby</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Povroznik</surname> <given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated levels of interleukin-27 in early life compromise protective immunity in a mouse model of gram-negative neonatal sepsis</article-title>. <source>Infect Immun</source>. (<year>2020</year>) <volume>88</volume>:<elocation-id>e00828-19</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00828-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31818960</pub-id></citation></ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kraft</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Horzempa</surname> <given-names>J</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Pena</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>Neonatal macrophages express elevated levels of interleukin-27 that oppose immune responses</article-title>. <source>Immunology</source>. (<year>2013</year>) <volume>139</volume>:<page-range>484&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imm.12095</pub-id>, PMID: <pub-id pub-id-type="pmid">23464355</pub-id></citation></ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Gleave Parson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kraft</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Lyda</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kobe</surname> <given-names>B</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner</article-title>. <source>Immunology</source>. (<year>2016</year>) <volume>149</volume>:<fpage>35</fpage>&#x2013;<lpage>47</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imm.12625</pub-id>, PMID: <pub-id pub-id-type="pmid">27238498</pub-id></citation></ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Leech</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Doyle</surname> <given-names>SL</given-names>
</name>
<name>
<surname>McLoughlin</surname> <given-names>RM</given-names>
</name>
</person-group>. <article-title>Staphylococcus aureus-induced immunosuppression mediated by IL-10 and IL-27 facilitates nasal colonisation</article-title>. <source>PloS Pathog</source>. (<year>2022</year>) <volume>18</volume>:<elocation-id>e1010647</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1010647</pub-id>, PMID: <pub-id pub-id-type="pmid">35776778</pub-id></citation></ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>S</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>IL-27 is elevated in acute lung injury and mediates inflammation</article-title>. <source>J Clin Immunol</source>. (<year>2013</year>) <volume>33</volume>:<page-range>1257&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10875-013-9923-0</pub-id>, PMID: <pub-id pub-id-type="pmid">23842867</pub-id></citation></ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Povroznik</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Akhter</surname> <given-names>H</given-names>
</name>
<name>
<surname>Vance</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Annamanedi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dziadowicz</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Interleukin-27-dependent transcriptome signatures during neonatal sepsis</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1124140</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1124140</pub-id>, PMID: <pub-id pub-id-type="pmid">36891292</pub-id></citation></ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazennec</surname> <given-names>G</given-names>
</name>
<name>
<surname>Rajarathnam</surname> <given-names>K</given-names>
</name>
<name>
<surname>Richmond</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>CXCR2 chemokine receptor - a master regulator in cancer and physiology</article-title>. <source>Trends Mol Med</source>. (<year>2024</year>) <volume>30</volume>:<fpage>37</fpage>&#x2013;<lpage>55</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molmed.2023.09.003</pub-id>, PMID: <pub-id pub-id-type="pmid">37872025</pub-id></citation></ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eash</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Greenbaum</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Gopalan</surname> <given-names>PK</given-names>
</name>
<name>
<surname>Link</surname> <given-names>DC</given-names>
</name>
</person-group>. <article-title>CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow</article-title>. <source>J Clin Invest</source>. (<year>2010</year>) <volume>120</volume>:<page-range>2423&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI41649</pub-id>, PMID: <pub-id pub-id-type="pmid">20516641</pub-id></citation></ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Han</surname> <given-names>X</given-names>
</name>
<name>
<surname>Teng</surname> <given-names>F</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Chemokine receptor CXCR-2 initiates atrial fibrillation by triggering monocyte mobilization in mice</article-title>. <source>Hypertension</source>. (<year>2020</year>) <volume>76</volume>:<page-range>381&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.120.14698</pub-id>, PMID: <pub-id pub-id-type="pmid">32639881</pub-id></citation></ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaczmarek</surname> <given-names>A</given-names>
</name>
<name>
<surname>Budzynska</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gospodarek</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Detection of K1 antigen of Escherichia coli rods isolated from pregnant women and neonates</article-title>. <source>Folia Microbiol (Praha)</source>. (<year>2014</year>) <volume>59</volume>:<page-range>419&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12223-014-0315-5</pub-id>, PMID: <pub-id pub-id-type="pmid">24737297</pub-id></citation></ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Justus</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Leffler</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ruiz-Echevarria</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>LV</given-names>
</name>
</person-group>. <article-title>
<italic>In vitro</italic> cell migration and invasion assays</article-title>. <source>J Vis Exp</source>. (<year>2014</year>) <volume>88</volume>:<elocation-id>51046</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3791/51046</pub-id>, PMID: <pub-id pub-id-type="pmid">24962652</pub-id></citation></ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Nau</surname> <given-names>GJ</given-names>
</name>
</person-group>. <article-title>Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis</article-title>. <source>J Infect Dis</source>. (<year>2008</year>) <volume>198</volume>:<page-range>359&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/589774</pub-id>, PMID: <pub-id pub-id-type="pmid">18557702</pub-id></citation></ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seman</surname> <given-names>BG</given-names>
</name>
<name>
<surname>Povroznik</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Vance</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Rawson</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>A neonatal imaging model of gram-negative bacterial sepsis</article-title>. <source>J Vis Exp</source>. (<year>2020</year>) <volume>162</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3791/61609</pub-id>, PMID: <pub-id pub-id-type="pmid">32865536</pub-id></citation></ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boon</surname> <given-names>K</given-names>
</name>
<name>
<surname>Vanalken</surname> <given-names>N</given-names>
</name>
<name>
<surname>Szpakowska</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chevigne</surname> <given-names>A</given-names>
</name>
<name>
<surname>Schols</surname> <given-names>D</given-names>
</name>
<name>
<surname>Van Loy</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over beta-arrestin recruitment and receptor internalization</article-title>. <source>Cell Commun Signal</source>. (<year>2024</year>) <volume>22</volume>:<fpage>43</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12964-023-01460-2</pub-id>, PMID: <pub-id pub-id-type="pmid">38233929</pub-id></citation></ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>A</given-names>
</name>
<name>
<surname>Eisenbarth</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>Structure and function of the immune system in the spleen</article-title>. <source>Sci Immunol</source>. (<year>2019</year>) <volume>4</volume>:<elocation-id>eaau6085</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciimmunol.aau6085</pub-id>, PMID: <pub-id pub-id-type="pmid">30824527</pub-id></citation></ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bronte</surname> <given-names>V</given-names>
</name>
<name>
<surname>Pittet</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>The spleen in local and systemic regulation of immunity</article-title>. <source>Immunity</source>. (<year>2013</year>) <volume>39</volume>:<page-range>806&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2013.10.010</pub-id>, PMID: <pub-id pub-id-type="pmid">24238338</pub-id></citation></ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chapman</surname> <given-names>RW</given-names>
</name>
<name>
<surname>Phillips</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Hipkin</surname> <given-names>RW</given-names>
</name>
<name>
<surname>Curran</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Lundell</surname> <given-names>D</given-names>
</name>
<name>
<surname>Fine</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>CXCR2 antagonists for the treatment of pulmonary disease</article-title>. <source>Pharmacol Ther</source>. (<year>2009</year>) <volume>121</volume>:<fpage>55</fpage>&#x2013;<lpage>68</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pharmthera.2008.10.005</pub-id>, PMID: <pub-id pub-id-type="pmid">19026683</pub-id></citation></ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsukawa</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hogaboam</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Lukacs</surname> <given-names>NW</given-names>
</name>
<name>
<surname>Kunkel</surname> <given-names>SL</given-names>
</name>
</person-group>. <article-title>Chemokines and innate immunity</article-title>. <source>Rev Immunogenet</source>. (<year>2000</year>) <volume>2</volume>:<page-range>339&#x2013;58</page-range>.</citation></ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Navarro-Xavier</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Newson</surname> <given-names>J</given-names>
</name>
<name>
<surname>Silveira</surname> <given-names>VL</given-names>
</name>
<name>
<surname>Farrow</surname> <given-names>SN</given-names>
</name>
<name>
<surname>Gilroy</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Bystrom</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties</article-title>. <source>J Immunol</source>. (<year>2010</year>) <volume>184</volume>:<page-range>1516&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0902866</pub-id>, PMID: <pub-id pub-id-type="pmid">20032295</pub-id></citation></ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rot</surname> <given-names>A</given-names>
</name>
<name>
<surname>McKimmie</surname> <given-names>C</given-names>
</name>
<name>
<surname>Burt</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Pallas</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Jamieson</surname> <given-names>T</given-names>
</name>
<name>
<surname>Pruenster</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor</article-title>. <source>J Immunol</source>. (<year>2013</year>) <volume>190</volume>:<page-range>6450&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1201429</pub-id>, PMID: <pub-id pub-id-type="pmid">23670187</pub-id></citation></ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Decreased CXCR2 expression on circulating monocytes of colorectal cancer impairs recruitment and induces Re-education of tumor-associated macrophages</article-title>. <source>Cancer Lett</source>. (<year>2022</year>) <volume>529</volume>:<page-range>112&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.canlet.2022.01.004</pub-id>, PMID: <pub-id pub-id-type="pmid">34999169</pub-id></citation></ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Shea</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Wollenberg</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Ao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Deming</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Sofroniew</surname> <given-names>MV</given-names>
</name>
</person-group>. <article-title>Foreign body responses in mouse central nervous system mimic natural wound responses and alter biomaterial functions</article-title>. <source>Nat Commun</source>. (<year>2020</year>) <volume>11</volume>:<fpage>6203</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-020-19906-3</pub-id>, PMID: <pub-id pub-id-type="pmid">33277474</pub-id></citation></ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seman</surname> <given-names>BG</given-names>
</name>
<name>
<surname>Vance</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Akers</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>Neonatal low-density granulocytes internalize and kill bacteria but suppress monocyte function using extracellular DNA</article-title>. <source>J Cell Sci</source>. (<year>2021</year>) <volume>134</volume>:<elocation-id>jcs252528</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/jcs.252528</pub-id>, PMID: <pub-id pub-id-type="pmid">33589502</pub-id></citation></ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korbecki</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kupnicka</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chlubek</surname> <given-names>M</given-names>
</name>
<name>
<surname>Goracy</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gutowska</surname> <given-names>I</given-names>
</name>
<name>
<surname>Baranowska-Bosiacka</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>CXCR2 receptor: regulation of expression, signal transduction, and involvement in cancer</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<elocation-id>2168</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23042168</pub-id>, PMID: <pub-id pub-id-type="pmid">35216283</pub-id></citation></ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auffray</surname> <given-names>C</given-names>
</name>
<name>
<surname>Sieweke</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Geissmann</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Blood monocytes: development, heterogeneity, and relationship with dendritic cells</article-title>. <source>Annu Rev Immunol</source>. (<year>2009</year>) <volume>27</volume>:<page-range>669&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132557</pub-id>, PMID: <pub-id pub-id-type="pmid">19132917</pub-id></citation></ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Furth</surname> <given-names>R</given-names>
</name>
<name>
<surname>Cohn</surname> <given-names>ZA</given-names>
</name>
</person-group>. <article-title>The origin and kinetics of mononuclear phagocytes</article-title>. <source>J Exp Med</source>. (<year>1968</year>) <volume>128</volume>:<page-range>415&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.128.3.415</pub-id>, PMID: <pub-id pub-id-type="pmid">5666958</pub-id></citation></ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geissmann</surname> <given-names>F</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>S</given-names>
</name>
<name>
<surname>Littman</surname> <given-names>DR</given-names>
</name>
</person-group>. <article-title>Blood monocytes consist of two principal subsets with distinct migratory properties</article-title>. <source>Immunity</source>. (<year>2003</year>) <volume>19</volume>:<fpage>71</fpage>&#x2013;<lpage>82</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1074-7613(03)00174-2</pub-id>, PMID: <pub-id pub-id-type="pmid">12871640</pub-id></citation></ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serbina</surname> <given-names>NV</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hohl</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Pamer</surname> <given-names>EG</given-names>
</name>
</person-group>. <article-title>Monocyte-mediated defense against microbial pathogens</article-title>. <source>Annu Rev Immunol</source>. (<year>2008</year>) <volume>26</volume>:<page-range>421&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.immunol.26.021607.090326</pub-id>, PMID: <pub-id pub-id-type="pmid">18303997</pub-id></citation></ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>B</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Splenectomy provides protective effects against CLP-induced sepsis by reducing TRegs and PD-1/PD-L1 expression</article-title>. <source>Int J Biochem Cell Biol</source>. (<year>2021</year>) <volume>136</volume>:<fpage>105970</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biocel.2021.105970</pub-id>, PMID: <pub-id pub-id-type="pmid">33774183</pub-id></citation></ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schupp</surname> <given-names>T</given-names>
</name>
<name>
<surname>Weidner</surname> <given-names>K</given-names>
</name>
<name>
<surname>Rusnak</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jawhar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Forner</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dulatahu</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Diagnostic and prognostic value of the AST/ALT ratio in patients with sepsis and septic shock</article-title>. <source>Scand J Gastroenterol</source>. (<year>2023</year>) <volume>58</volume>:<fpage>392</fpage>&#x2013;<lpage>402</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/00365521.2022.2131331</pub-id>, PMID: <pub-id pub-id-type="pmid">36259154</pub-id></citation></ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panteghini</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Aspartate aminotransferase isoenzymes</article-title>. <source>Clin Biochem</source>. (<year>1990</year>) <volume>23</volume>:<page-range>311&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0009-9120(90)80062-N</pub-id>, PMID: <pub-id pub-id-type="pmid">2225456</pub-id></citation></ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>RZ</given-names>
</name>
<name>
<surname>Park</surname> <given-names>S</given-names>
</name>
<name>
<surname>Reagan</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Goldstein</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lawton</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Alanine aminotransferase isoenzymes: molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity</article-title>. <source>Hepatology</source>. (<year>2009</year>) <volume>49</volume>:<fpage>598</fpage>&#x2013;<lpage>607</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/hep.22657</pub-id>, PMID: <pub-id pub-id-type="pmid">19085960</pub-id></citation></ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ndrepepa</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Aspartate aminotransferase and cardiovascular disease&#x2014;a narrative review</article-title>. <source>J Lab Precis Med</source>. (<year>2020</year>) <volume>6</volume>:<fpage>6</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/jlpm-20-93</pub-id>
</citation></ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lappin</surname> <given-names>E</given-names>
</name>
<name>
<surname>Ferguson</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>Gram-positive toxic shock syndromes</article-title>. <source>Lancet Infect Dis</source>. (<year>2009</year>) <volume>9</volume>:<page-range>281&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1473-3099(09)70066-0</pub-id>, PMID: <pub-id pub-id-type="pmid">19393958</pub-id></citation></ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Priyanka</surname> <given-names>S</given-names>
</name>
<name>
<surname>Morkar</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>AST/ALT Ratio as an indicator of functional severity in chronic heart failure with reduced left ventricular ejection fraction: A prospective cross-sectional study</article-title>. <source>Indian Heart J</source>. (<year>2024</year>) <volume>76</volume>:<page-range>202&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ihj.2024.06.004</pub-id>, PMID: <pub-id pub-id-type="pmid">38897408</pub-id></citation></ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basha</surname> <given-names>S</given-names>
</name>
<name>
<surname>Surendran</surname> <given-names>N</given-names>
</name>
<name>
<surname>Pichichero</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Immune responses in neonates</article-title>. <source>Expert Rev Clin Immunol</source>. (<year>2014</year>) <volume>10</volume>:<page-range>1171&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1586/1744666X.2014.942288</pub-id>, PMID: <pub-id pub-id-type="pmid">25088080</pub-id></citation></ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zea-Vera</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ochoa</surname> <given-names>TJ</given-names>
</name>
</person-group>. <article-title>Challenges in the diagnosis and management of neonatal sepsis</article-title>. <source>J Trop Pediatr</source>. (<year>2015</year>) <volume>61</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/tropej/fmu079</pub-id>, PMID: <pub-id pub-id-type="pmid">25604489</pub-id></citation></ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MaChado</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Soave</surname> <given-names>DF</given-names>
</name>
<name>
<surname>da Silva</surname> <given-names>MV</given-names>
</name>
<name>
<surname>de Menezes</surname> <given-names>LB</given-names>
</name>
<name>
<surname>Etchebehere</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Monteiro</surname> <given-names>ML</given-names>
</name>
<etal/>
</person-group>. <article-title>Neonatal sepsis and inflammatory mediators</article-title>. <source>Mediators Inflamm</source>. (<year>2014</year>) <volume>2014</volume>:<fpage>269681</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2014/269681</pub-id>, PMID: <pub-id pub-id-type="pmid">25614712</pub-id></citation></ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Cytokine regulation of immune tolerance</article-title>. <source>Burns Trauma</source>. (<year>2014</year>) <volume>2</volume>:<page-range>11&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/2321-3868.124771</pub-id>, PMID: <pub-id pub-id-type="pmid">27574641</pub-id></citation></ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudhry</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>MM</given-names>
</name>
<name>
<surname>McGuire</surname> <given-names>F</given-names>
</name>
<name>
<surname>Nagarkatti</surname> <given-names>PS</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of cytokines as a double-edged sword in sepsis</article-title>. <source>In Vivo</source>. (<year>2013</year>) <volume>27</volume>:<page-range>669&#x2013;84</page-range>. PMID: <pub-id pub-id-type="pmid">24292568</pub-id></citation></ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>Interleukin-27 inhibits phagosomal acidification by blocking vacuolar ATPases</article-title>. <source>Cytokine</source>. (<year>2013</year>) <volume>62</volume>:<page-range>202&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cyto.2013.03.010</pub-id>, PMID: <pub-id pub-id-type="pmid">23557795</pub-id></citation></ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>IL-12 and IL-27 regulate the phagolysosomal pathway in mycobacteria-infected human macrophages</article-title>. <source>Cell Commun Signal</source>. (<year>2014</year>) <volume>12</volume>:<fpage>16</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1478-811X-12-16</pub-id>, PMID: <pub-id pub-id-type="pmid">24618498</pub-id></citation></ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olson</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Ley</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Chemokines and chemokine receptors in leukocyte trafficking</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source>. (<year>2002</year>) <volume>283</volume>:<fpage>R7</fpage>&#x2013;<lpage>28</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpregu.00738.2001</pub-id>, PMID: <pub-id pub-id-type="pmid">12069927</pub-id></citation></ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummings</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>TR</given-names>
</name>
<name>
<surname>Frevert</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Quan</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>VA</given-names>
</name>
<name>
<surname>Mongovin</surname> <given-names>SM</given-names>
</name>
<etal/>
</person-group>. <article-title>Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis</article-title>. <source>J Immunol</source>. (<year>1999</year>) <volume>162</volume>:<page-range>2341&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.162.4.2341</pub-id>, PMID: <pub-id pub-id-type="pmid">9973513</pub-id></citation></ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rios-Santos</surname> <given-names>F</given-names>
</name>
<name>
<surname>Alves-Filho</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Souto</surname> <given-names>FO</given-names>
</name>
<name>
<surname>Spiller</surname> <given-names>F</given-names>
</name>
<name>
<surname>Freitas</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lotufo</surname> <given-names>CM</given-names>
</name>
<etal/>
</person-group>. <article-title>Down-regulation of CXCR2 on neutrophils in severe sepsis is mediated by inducible nitric oxide synthase-derived nitric oxide</article-title>. <source>Am J Respir Crit Care Med</source>. (<year>2007</year>) <volume>175</volume>:<page-range>490&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.200601-103OC</pub-id>, PMID: <pub-id pub-id-type="pmid">17138957</pub-id></citation></ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname> <given-names>ZB</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Jing</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>YW</given-names>
</name>
<name>
<surname>Pei</surname> <given-names>G</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>BZ</given-names>
</name>
<etal/>
</person-group>. <article-title>OxLDL upregulates CXCR2 expression in monocytes via scavenger receptors and activation of p38 mitogen-activated protein kinase</article-title>. <source>Cardiovasc Res</source>. (<year>2002</year>) <volume>53</volume>:<page-range>524&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0008-6363(01)00491-6</pub-id>, PMID: <pub-id pub-id-type="pmid">11827704</pub-id></citation></ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Luan</surname> <given-names>T</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>CXCR2 expression on granulocyte and macrophage progenitors under tumor conditions contributes to mo-MDSC generation via SAP18/ERK/STAT3</article-title>. <source>Cell Death Dis</source>. (<year>2019</year>) <volume>10</volume>:<fpage>598</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-019-1837-1</pub-id>, PMID: <pub-id pub-id-type="pmid">31395859</pub-id></citation></ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dyer</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Pallas</surname> <given-names>K</given-names>
</name>
<name>
<surname>Medina-Ruiz</surname> <given-names>L</given-names>
</name>
<name>
<surname>Schuette</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Graham</surname> <given-names>GJ</given-names>
</name>
</person-group>. <article-title>CXCR2 deficient mice display macrophage-dependent exaggerated acute inflammatory responses</article-title>. <source>Sci Rep</source>. (<year>2017</year>) <volume>7</volume>:<fpage>42681</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep42681</pub-id>, PMID: <pub-id pub-id-type="pmid">28205614</pub-id></citation></ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawrence</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Corriden</surname> <given-names>R</given-names>
</name>
<name>
<surname>Nizet</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Age-appropriate functions and dysfunctions of the neonatal neutrophil</article-title>. <source>Front Pediatr</source>. (<year>2017</year>) <volume>5</volume>:<elocation-id>23</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fped.2017.00023</pub-id>, PMID: <pub-id pub-id-type="pmid">28293548</pub-id></citation></ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fox</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Maheshwari</surname> <given-names>A</given-names>
</name>
<name>
<surname>Christensen</surname> <given-names>RD</given-names>
</name>
<name>
<surname>Calhoun</surname> <given-names>DA</given-names>
</name>
</person-group>. <article-title>The effects and comparative differences of neutrophil specific chemokines on neutrophil chemotaxis of the neonate</article-title>. <source>Cytokine</source>. (<year>2005</year>) <volume>29</volume>:<page-range>135&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cyto.2004.10.007</pub-id>, PMID: <pub-id pub-id-type="pmid">15613281</pub-id></citation></ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname> <given-names>J</given-names>
</name>
<name>
<surname>Scheckenbach</surname> <given-names>V</given-names>
</name>
<name>
<surname>Kugel</surname> <given-names>H</given-names>
</name>
<name>
<surname>Spring</surname> <given-names>B</given-names>
</name>
<name>
<surname>Pagel</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hartel</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Granulocytic myeloid-derived suppressor cells (GR-MDSC) accumulate in cord blood of preterm infants and remain elevated during the neonatal period</article-title>. <source>Clin Exp Immunol</source>. (<year>2018</year>) <volume>191</volume>:<page-range>328&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cei.13059</pub-id>, PMID: <pub-id pub-id-type="pmid">28963753</pub-id></citation></ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gervassi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lejarcegui</surname> <given-names>N</given-names>
</name>
<name>
<surname>Dross</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jacobson</surname> <given-names>A</given-names>
</name>
<name>
<surname>Itaya</surname> <given-names>G</given-names>
</name>
<name>
<surname>Kidzeru</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Myeloid derived suppressor cells are present at high frequency in neonates and suppress <italic>in vitro</italic> T cell responses</article-title>. <source>PloS One</source>. (<year>2014</year>) <volume>9</volume>:<fpage>e107816</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0107816</pub-id>, PMID: <pub-id pub-id-type="pmid">25248150</pub-id></citation></ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vance</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Rawson</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Povroznik</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Brundage</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>Myeloid-derived suppressor cells gain suppressive function during neonatal bacterial sepsis</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>:<elocation-id>7047</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms22137047</pub-id>, PMID: <pub-id pub-id-type="pmid">34208904</pub-id></citation></ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gleave Parson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Grimmett</surname> <given-names>J</given-names>
</name>
<name>
<surname>Vance</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Witt</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Seman</surname> <given-names>BG</given-names>
</name>
<name>
<surname>Rawson</surname> <given-names>TW</given-names>
</name>
<etal/>
</person-group>. <article-title>Murine myeloid-derived suppressor cells are a source of elevated levels of interleukin-27 in early life and compromise control of bacterial infection</article-title>. <source>Immunol Cell Biol</source>. (<year>2019</year>) <volume>97</volume>:<page-range>445&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imcb.12224</pub-id>, PMID: <pub-id pub-id-type="pmid">30575117</pub-id></citation></ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wickel</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Cheadle</surname> <given-names>WG</given-names>
</name>
<name>
<surname>Mercer-Jones</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Garrison</surname> <given-names>RN</given-names>
</name>
</person-group>. <article-title>Poor outcome from peritonitis is caused by disease acuity and organ failure, not recurrent peritoneal infection</article-title>. <source>Ann Surg</source>. (<year>1997</year>) <volume>225</volume>:<page-range>744&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00000658-199706000-00012</pub-id>, PMID: <pub-id pub-id-type="pmid">9230815</pub-id></citation></ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Azambuja Rodrigues</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Valente</surname> <given-names>RH</given-names>
</name>
<name>
<surname>Brunoro</surname> <given-names>GVF</given-names>
</name>
<name>
<surname>Nakaya</surname> <given-names>HTI</given-names>
</name>
<name>
<surname>Araujo-Pereira</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bozza</surname> <given-names>PT</given-names>
</name>
<etal/>
</person-group>. <article-title>Proteomics reveals disturbances in the immune response and energy metabolism of monocytes from patients with septic shock</article-title>. <source>Sci Rep</source>. (<year>2021</year>) <volume>11</volume>:<fpage>15149</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-94474-0</pub-id>, PMID: <pub-id pub-id-type="pmid">34312428</pub-id></citation></ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salomao</surname> <given-names>R</given-names>
</name>
<name>
<surname>Brunialti</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Rapozo</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Baggio-Zappia</surname> <given-names>GL</given-names>
</name>
<name>
<surname>Galanos</surname> <given-names>C</given-names>
</name>
<name>
<surname>Freudenberg</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Bacterial sensing, cell signaling, and modulation of the immune response during sepsis</article-title>. <source>Shock</source>. (<year>2012</year>) <volume>38</volume>:<page-range>227&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/SHK.0b013e318262c4b0</pub-id>, PMID: <pub-id pub-id-type="pmid">22777111</pub-id></citation></ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavaillon</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Adib-Conquy</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis</article-title>. <source>Crit Care</source>. (<year>2006</year>) <volume>10</volume>:<fpage>233</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/cc5055</pub-id>, PMID: <pub-id pub-id-type="pmid">17044947</pub-id></citation></ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Carmo</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Brunialti</surname> <given-names>MK</given-names>
</name>
<name>
<surname>MaChado</surname> <given-names>FR</given-names>
</name>
<name>
<surname>Azevedo</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Assuncao</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Modulation of monocytes in septic patients: preserved phagocytic activity, increased ROS and NO generation, and decreased production of inflammatory cytokines</article-title>. <source>Intensive Care Med Exp</source>. (<year>2016</year>) <volume>4</volume>:<fpage>5</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40635-016-0078-1</pub-id>, PMID: <pub-id pub-id-type="pmid">26879814</pub-id></citation></ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Marion</surname> <given-names>TN</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Park 7: A novel therapeutic target for macrophages in sepsis-induced immunosuppression</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>:<elocation-id>2632</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02632</pub-id>, PMID: <pub-id pub-id-type="pmid">30542343</pub-id></citation></ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Surbatovic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Veljovic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jevdjic</surname> <given-names>J</given-names>
</name>
<name>
<surname>Popovic</surname> <given-names>N</given-names>
</name>
<name>
<surname>Djordjevic</surname> <given-names>D</given-names>
</name>
<name>
<surname>Radakovic</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Immunoinflammatory response in critically ill patients: severe sepsis and/or trauma</article-title>. <source>Mediators Inflamm</source>. (<year>2013</year>) <volume>2013</volume>:<fpage>362793</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2013/362793</pub-id>, PMID: <pub-id pub-id-type="pmid">24371374</pub-id></citation></ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doganyigit</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Eroglu</surname> <given-names>E</given-names>
</name>
<name>
<surname>Akyuz</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Inflammatory mediators of cytokines and chemokines in sepsis: From bench to bedside</article-title>. <source>Hum Exp Toxicol</source>. (<year>2022</year>) <volume>41</volume>:<fpage>9603271221078871</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/09603271221078871</pub-id>, PMID: <pub-id pub-id-type="pmid">35337213</pub-id></citation></ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mueller</surname> <given-names>SG</given-names>
</name>
<name>
<surname>White</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Schraw</surname> <given-names>WP</given-names>
</name>
<name>
<surname>Lam</surname> <given-names>V</given-names>
</name>
<name>
<surname>Richmond</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor</article-title>. <source>J Biol Chem</source>. (<year>1997</year>) <volume>272</volume>:<page-range>8207&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.272.13.8207</pub-id>, PMID: <pub-id pub-id-type="pmid">9079638</pub-id></citation></ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bauer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Press</surname> <given-names>AT</given-names>
</name>
</person-group>. <article-title>The immunological function of CXCR2 in the liver during sepsis</article-title>. <source>J Inflammation (Lond)</source>. (<year>2022</year>) <volume>19</volume>:<fpage>23</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12950-022-00321-y</pub-id>, PMID: <pub-id pub-id-type="pmid">36451225</pub-id></citation></ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ness</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Hogaboam</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Strieter</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Kunkel</surname> <given-names>SL</given-names>
</name>
</person-group>. <article-title>Immunomodulatory role of CXCR2 during experimental septic peritonitis</article-title>. <source>J Immunol</source>. (<year>2003</year>) <volume>171</volume>:<page-range>3775&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.171.7.3775</pub-id>, PMID: <pub-id pub-id-type="pmid">14500678</pub-id></citation></ref>
</ref-list>
</back>
</article>